Rise of GLP-1 drugs brings substantial litigation risk: DAC Beachcroft
Reinsurance News - Dec 18, 2025
Law firm DAC Beachcroft warns of surging product liability claims that come with the rise of popular Glucagon-like peptide-1 receptor agonists (or GLP-1s), drugs for obesity management. While drugs like Ozempic and Wegowy offer health benefits, their rapid adoption has sparked a wave of legal challe...
Recommended Articles
Posted: Apr 16, 2026
Capgemini Research Institute, the research division of the Capgemini, has published the report Physi...
Posted: Apr 16, 2026
Beazley, a large specialist insurer, has announced plans to establish a new Marine War insurance con...
Posted: Apr 16, 2026
John Doyle, President and Chief Executive Officer (CEO) of global insurance and reinsurance broking...